August 2026– date –
-
AI Transforms Hematopoietic Stem Cell Research: Digital Twins and Reinforcement Learning Applied from Disease Modeling to Industrial CAR-T Cell Manufacturing
Baishideng Publishing Group Global Overview Artificial Intelligence (AI) shows vast potential in hematopoietic stem cell (HSC) research and related malignancies, spanning from disease modeling to cell manufacturing. Notably, digital twin... -
Asia, Led by Japan, Emerges as Global Clinical Research Hub, Fueled by Government Investment in Regenerative Medicine and Advanced Biomanufacturing
GlobalData Japan Overview Asia, particularly Japan, is rapidly emerging as a global hub for clinical research innovation. Japan ranked among the top 5 countries globally for clinical trial growth between Q2 2024 and Q2 2025. This signifi... -
Integration of Digital Twins, AI, PAT, and IoT Revolutionizes Single-Use Mixing Solutions in Bioprocess Engineering for Enhanced Robustness
Facebook Global Overview In bioprocess engineering, the selection of single-use mixing solutions is significantly advanced by integrating digital twin technology, AI/machine learning (ML), Process Analytical Technology (PAT), IoT, and so... -
Corning Life Sciences Expands Advanced 3D Cell Culture and Bioprocess Solutions, Accelerating Research and Clinical Translation
Corning USA Overview Corning Life Sciences is continuously enhancing its portfolio of 3D cell culture models, stem cell research tools, bioprocess solutions, and cell therapy products. The company's offerings aim to replicate in vivo fun... -
KOLON Biotech Expands Comprehensive CDMO Services in Korea, Specializing in Cell, Gene, and Exosome Therapies
MTEC South Korea Overview KOLON Biotech in South Korea is bolstering its capabilities as a specialized Contract Development and Manufacturing Organization (CDMO) for advanced cell, gene, and exosome therapies. The company offers end-to-e... -
Drastic Cost Reduction in Biosimilar Manufacturing: Integrated Strategies of Continuous Bioprocessing, QbD, Single-Use Systems, and AI
Pharma Advancement USA Overview Integrated strategies including continuous bioprocessing with high-density cell culture, Quality by Design (QbD) with Process Analytical Technology (PAT), single-use systems with modular facility design, a... -
The Medicine Maker Forecasts Commercial-Scale iPSC Cell Therapy Hinges on Allogeneic Advances and Manufacturing Bottleneck Resolution
The Medicine Maker UK Overview The Medicine Maker reports that commercial-scale iPSC cell therapy hinges on the evolution of allogeneic cell therapies and the resolution of manufacturing bottlenecks. Stefan Braam, CTO of Cellistic, discu... -
Bioprocess Insider Reports AI Tools Revolutionize Antibody Design, Viral Titer Measurement, and Workforce Readiness in Minutes, Optimizing Gene Therapy Manufacturing
Bioprocess Insider UK Overview Bioprocess Insider reports that AI tools are driving extensive innovations in bioprocessing, with GeneData presenting an end-to-end optimization platform and BioCurie developing real-time rAAV (recombinant ... -
EIT Food Report: European Consumer Trust Gap Impedes Next-Gen Food Tech Adoption
Food Ingredients First (via EIT Food) Belgium Overview A recent EIT Food report indicates that while European consumers generally hold a positive view of food innovation, acceptance of novel technologies like cultivated meat and precisio... -
FERM-AI Optimizes Microbial Cellulase Fermentation with Risk-Aware Machine Learning, Balancing Productivity and Contamination Risk
Frontiers Switzerland Overview A study published in Frontiers introduces FERM-AI, a novel risk-aware machine learning framework designed to optimize microbial cellulase fermentation. This system integrates yield prediction, contamination...
